Oramed to Present at H.C. Wainwright 23rd Annual Global Investment Conference
NEW YORK, Sept. 9, 2021 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Chief Executive Officer Nadav Kidron will present a company overview at the H.C. Wainwright 23rd Annual Global Investment Conference, on September 13, 2021. The conference will […]
